Posted in | News | Nanoanalysis | Nanobusiness

NanoSight Releases Latest NS200 Nanoparticle Characterization System

NanoSight, world-leading manufacturers of unique nanoparticle characterization technology announce the release of their latest NS200 nanoparticle characterization system. It will be shown and demonstrated for the first time at the renowned US Pittsburgh Conference and Exposition being held in 2011 in Atlanta, Georgia from March 14 until 17th, booth #519.

Based on the well-adopted LM20 model applying their unique particle-by-particle visualization and counting method, Nanoparticle Tracking Analysis or NTA, NanoSight has taken advantage of developments in hardware to produce an easier-to-use instrument with a high sensitivity camera built into the housing of the system.

Scatter diagram showing high performance using NanoSight NTA for polydisperse samples

With optimized locators for making it very easy to position the measurement cell and with an electronic readout of the cell test temperature, NanoSight have set out producing a design of instrument to meet the growing need for systems with a recognised SOP, standard operating procedure.

The system has an optional blue laser to improve imaging capability, and fluorescence filters can be added when working with suitably labelled particles. The EMCCD (electron multiplying CCD) camera is designed with maximal speed and sensitivity in mind. With 37 full frames/second collected directly through a universal USB2.0 interface, the EMCCD has greatly enhanced performance over the standard CCD previously supplied. Furthermore, the laser in the NS200 is triggered to reduce thermal issues with respect to the sample, restricting photobleaching during fluorescence imaging.

The end result is a ruggedly constructed instrument which requires minimal operator skills. Training is very rapid and operators can produce consistent results within a very short time from introduction.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.